Browsing Tag
Thermo Fisher Scientific Inc.
3 posts
Genedrive partners with Thermo Fisher as $GDR targets high-throughput NHS testing
Genedrive has signed a development agreement with Thermo Fisher Scientific for a high-throughput CYP2C19 assay, potentially expanding its stroke-testing business from hospital wards into central NHS genomic laboratories.
Why pancreatic cancer clinicians and investors are closely watching AIM ImmunoTech’s next move
AIM ImmunoTech’s next Ampligen move could reshape pancreatic cancer treatment and investor sentiment. Find out what executives and markets are watching now.
Thermo Fisher raises $2.5bn in bonds—But what’s the bigger play behind the debt move?
Thermo Fisher Scientific priced $2.5B in senior notes to fuel acquisitions, refinancing, and growth. See how the deal shapes TMO’s 2026 outlook.